You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Empagliflozin in combination therapy for treating type 2 diabetes

  • Technology appraisal guidance
  • Reference number: TA336
  • Published:  25 March 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Diabetes (type 2) - empagliflozin [ID641]: final appraisal determination document

Diabetes (type 2) - empagliflozin [ID641]: final appraisal determination document Diabetes (type 2) - empagliflozin [ID641]: final appraisal determination document
22 January 2015
(494.33 Kb 23 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 19 January 2015

Back to top